AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Aug 26, 2015
29828_dirs_2015-08-26_6b62c720-267a-4d23-a1b8-517c78c3a232.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-08-21
Reporting Person: MARTIN JOHN C (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-21 | Common Stock | G | 133213 | — | Disposed | 4081279 | Direct |
| 2015-08-24 | Common Stock | G | 133213 | — | Disposed | 3948066 | Direct |
| 2015-08-24 | Common Stock | A | 133213 | — | Acquired | 133213 | Indirect |
| 2015-08-25 | Common Stock | S | 59800 | $104.3258 | Disposed | 73413 | Indirect |
| 2015-08-25 | Common Stock | S | 56613 | $105.679 | Disposed | 16800 | Indirect |
| 2015-08-25 | Common Stock | S | 16800 | $106.4514 | Disposed | 0 | Indirect |
Footnotes
F1: Shares gifted to charitable trust
F2: Sale prices reported for the transactions reported here range from $104.17 to $105.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3: Sale prices reported for the transactions reported here range from $105.20 to $106.19. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $106.23 to $106.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.